Additionally, by targeting inflammatory cascades such as the calpain/calpastatin system and the IL-1α/IL-1β to IL-1Ra ratio, we can then potentially halt the inflammatory-mediated corneal thinning seen in KC. This evidence concerns the gene CAST and keratoconus.